I believe Vivo has the right approach to precision controlled mhm cultivation- dosing and compound levels will be key in expanding medical market and achieving legitimacy as a treatment... Im just pointing out that they have been promising a German license and have been unable to secure one- I thght the appointment of a Pres of op in Germany wld be indicative of an expectation of a license but I guess the delays continue.
Not too worried but it’s rather disappointing when they don’t hit benchmarks they have set for themselves- I am really excited abt the developments out of Australia- hope they can get clinical trials to later stages
News 
Market Data 
Discover 
